drugset / Trial / NCT05895162

Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.

NCT05895162 ↗

Completed 64 enrolled FEMPHARMA Kft.
RandomizedParallel-groupOpen-labelTreatment

Summary

Vaginitis is one of the most common gynecological problems in women. Candida albicans is responsible for more than 85% of vaginal fungal infections and reinfection after standard treatment is quite common. The aim of this study is to compare the effects of a zinc-containing vaginal gel and oral fluconazole on the treatment and recurrence of vulvovaginal candidiasis (VVC). The investigator's hypothesis is that zinc-containing vaginal gel may decrease the rate of reinfection after standard treatment with oral 150 mg fluconazole.

Timeline

Start
2023-06-10
Primary completion
2026-04-20
Completion
2026-04-20

Drugs

EvaluationDrugModalityDoseRoute
Subject JUVIA Unknown — Other
Background Fluconazole Small molecule 150 mg —